Anti-peptide antibodies that cross react with protective antigen of and uses thereof

Antibodies to NTB-A

Peptides for active anti-cytokine immunization

GPCR crystalization method using an antibody

Co-crystal structure of factor D and anti-factor D antibody

IGF-II/IGF-IIE BINDING PROTEINS

Specific ligands to sortilin

Crystal structure of the CCZ-LZ domain of NEMO

Crystallographic structure of Mnk-1 and Mnk-2 proteins

Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof

Crystalline composition of GM-CSF/GM-CSFR

Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof

Crystal of egfr extracellular domain and cetuximab fab fragment, and uses thereof

Method for generating information related to the molecular structure of a biomolecule

Alpha-amylase variants with altered properties

Crystal structure of the influenza virus polymerase PAC-PB1complex and uses thereof

Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

Peptide that binds to a broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex, uses thereof, compositions therefrom

Generation and affinity maturation of antibody library in silico

Crystal form of the amyloid precursor protein intracellular domain (AICD) in complex with human FE65-PTB2

METHOD OF RATIONAL-BASED DRUG DESIGN USING OSTEOCALCIN

ADAM-15 antibodies and immunogenic peptides

CRYSTAL STRUCTURE

Humanized anti-nerve growth factor antibodies

Method for the humanization of antibodies and humanized antibodies thereby obtained

MEANS FOR TREATING MYOSIN-RELATED DISEASES

Crystal structure of Aurora-2 protein and binding pockets thereof

PRODUCTS AND PROCESSES FOR MODULATING PEPTIDE-PEPTIDE BINDING DOMAIN INTERACTIONS

RNA polymerase derived from influenza virus

Method for the treatment of pain with humanized anti-nerve growth factor antibodies

CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT

Receptor modulators

Method of inhibiting HIV-1 binding to genital epithelia using V3 loop-specific peptides and GP340-specific antibodies

Three-dimensional structure of isoprene synthase and its use thereof for generating variants

HIGH PRESSURE PROTEIN CRYSTALLIZATION

LXR LIGAND BINDING DOMAIN (LXR LBD) CRYSTALS

Structure of compstatin-C3 complex and use for rational drug design

ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

REGULATORS OF MMP-9 AND USES THEROF

ANTIBODY DESIGN USING ANTI-LIPID ANTIBODY CRYSTAL STRUCTURES

AC FIELD INDUCED BIOMOLECULE CYRSTALLIZATION AND HYDRATION CAGE DISRUPTION

Methods and compositions for obtaining high-resolution crystals of membrane proteins

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

CRYSTALLINE VAP-1 AND USES THEREOF

Chalcone isomerase polypeptides and crystals thereof

CRYSTALLIZATION OF ANTI-CD20 ANTIBODIES

Structure of the farnesoid X receptor ligand binding domain and methods of use therefor

Crystal structure of human JAK3 kinase domain complex and binding pockets thereof

CRYSTAL STRUCTURE OF THE COMPLEX OF HEPATOCYTE GROWTH FACTOR BETA CHAIN WITH MET RECEPTOR AND METHODS OF USE

Methods for identifying inhibitors against viruses that use a class I fusion protein

Method for Identifying an inhibitor of plasmidic classic C beta-lactamase having extended-substrate specifity

Soluble fragments of influenza virus PB2 protein capable of binding RNA-cap

Insulin degrading enzyme crystals

Ribosome Structure and Protein Synthesis Inhibitors

HDM2-inhibitor complexes and uses thereof

Switch-region: target and method for inhibition of bacterial RNA polymerase

Malonate decarboxylases for industrial applications

Crystal Structure of a MarR Family Polypeptide

METHODS FOR INHIBITING FASCIN

Crystal structure of a plasma membrane proton pump

Information processing system using base sequence relevant information

Humanized platelet activating factor antibody design using anti-lipid antibody templates

Antibiotics and Methods For Producing Them

Crystal structure of CRIg and C3b:CRIg complex

Crystal of GTP Cyclohydrolase Type IB

Molecular markers of plant embryogenesis

Anticalins

CRYSTAL STRUCTURE OF HEPATOCYTE GROWTH FACTOR ACTIVATOR COMPLEXED WITH KUNITZ DOMAIN INHIBITOR

Antibodies against human NKG2D and uses thereof

Antibodies to VLA-1

Structure of the insulin receptor ectodomain

COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF

HDM2 polypeptides

Kinase domain polypeptide of human protein kinase B gamma (AKT3)

Methods and Structural Conformations of Antibody Preparations with Increased Resistance to Proteases

Kallikrein 7 modulators

Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same

Engineered proteins with high affinity for DOTA chelates

Crystal structure of CD147 extracellular region and use thereof

USE OF THE PROTIEN MABA (FABG1) OF MYCOBACTERIUM TUBERCULOSIS FOR DESIGNING AND SCREENING ANTIBIOTICS

Crystal structure of thyroid stimulating hormone receptor

Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

Methods

Crystals of human glutamic acid decarboxylase 65 (GAD65)

Method of preparing a dough-based product

Ribosome structure and protein synthesis inhibitors

Refolded recombinant β-secretase crystals and methods for preparing and using the same

FUNCTIONAL HUMANIZATION OF COMPLEMENTARITY DETERMINING REGIONS (CDRS)

Methods and compositions related to the structure and function of APOBEC3G

Protease variants

METHODS FOR CRYSTALLIZING ERK2 POLYPEPTIDES

Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof

Crystal structure of the N-terminal domain of angiotensin converting enzyme and uses thereof

CRYSTAL STRUCTURES OF HIV-1 PROTEASE INHIBITORS BOUND TO HIV-1 PROTEASE

Crystal structure of an angiotensin-converting enzyme (ACE) and uses thereof

Monoclonal antibodies against stromal derived factor-1 (SDF-1)

Diagnosis and treatment of infectious diseases through indel-differentiated proteins

Peptides for active anti-cytokine immunization

Anti-pan neuropilin antibody and binding fragments thereof

Binding members for IgE molecules

Method for crystallizing strain T1 polypeptide

Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides

Method for identifying protein synthesis inhibitors by ribosome structure

CRYSTAL STRUCTURE OF P53 MUTANTS AND THEIR USE

Antibodies against human interleukin-13 and uses therefor

CRYSTAL STRUCTURE OF BIFUNCTIONAL TRANSGLYCOSYLASE PBP1B FROM E. COLI AND INHIBITORS THEREOF

Molecular markers of plant embryogenesis

COMPLEXES OF NADP WITH THE PROTEIN MABA OF MYCOBACTERIUM TUBERCULOSIS OR WITH MUTANTS THEREOF, AND THEIR USES FOR DESIGNING AND SCREENING ANTIBIOTICS

Crystallization and Structure Determination of Glycosylated Human Beta Secretase, an Enzyme Implicated in Alzheimer's Disease

Lipolytic enzyme variants

Frizzled-binding agents and uses thereof

Alternative crystal form of monoacylglycerol lipase (MGLL)

MODULATORS OF PROTEIN PHOSPHATASE 2A

Allergen-binding IgE monoclonal antibodies and method for preparing hypoallergens

CO-CRYSTAL OF ANTIBODY 11F8FAB FRAGMENT AND EGFR EXTRACELLULAR DOMAIN AND USES THEREOF

Isolated antibody which specifically binds to PCSK9

Antibodies against human NKG2D and uses thereof

OB fold domains

FUNCTIONAL PROTEIN CRYSTALS CONTAINING A CORE NANO-PARTICLE AND USES THEREOF

ANTIBODY VARIANTS

MUTANT PROTEIN HAVING DIAPHORASE ACTIVITY

Crystalline anti-hTNFalpha antibodies

Products and processes for modulating peptide-peptide binding domain interactions

Three dimensional coordinates of HPTPbeta

Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

Modulation of Glutamine Synthetase Activity

Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

RESISTANCE-REPELLENT RETROVIRAL PROTEASE INHIBITORS

Crystal Structure of Enzyme and Uses Thereof

LIPOLYTIC ENZYME VARIANTS

FERMENTATIVE PREPARATION PROCESS FOR AND CRYSTAL FORMS OF CYTOSTATICS

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

Method for the humanization of antibodies and humanized antibodies thereby obtained

Recombinant soluble Fc receptors

MODULATORS OF PROTEIN PHOSPHATASE 2A HOLOENYME

Crystal structure of aurora-2 protein and binding pockets thereof

AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure

METHOD FOR DESIGNING MUTATED ENZYME, METHOD FOR PREPARING THE SAME, AND MUTATED ENZYME

Crystal structure of aldehyde dehydrogenase and methods of use thereof

Crystal structure of hepatocyte growth factor activator complexed with Kunitz domain inhibitor

Isolated peptides having phospholipase inhibitory activity

CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLATE CYCLASE

Methods of producing polyketide synthase mutants and compositions and uses thereof

Crystal structure of human factor VIII and uses thereof

CRYSTALLINE STRUCTURE OF OXIDOSQUALENE SYNTHASE

Crystal structure of monoacylglycerol lipase (MGLL)

Protein engineering of monoacylglycerol lipase (MGLL)

Influenza virus neuraminidase crystal structure and their use thereof

CRYSTAL STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR AMINO TEMINAL FRAGMENT BOUND TO ITS RECEPTOR

THREE-DIMENSIONAL STRUCTURE OF PROSTAGLANDIN D SYNTHASE AND UTILIZATION THEREOF

Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase

TARGET RECOGNIZING BINDING AGENTS

Soluble fusion proteins comprising heterologous polypeptides

Relaxase Modulators and Methods of Using Same

Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof

Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid

Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use Thereof

Crystal Structure of Ump Kinase and Uses Thereof

CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS

Process for generation of protein and uses therof

Subtilases

Crystal structure of soluble glutaminyl cyclase

Compositions and methods for crystallizing antibody fragments

CRYSTALLIZATION OF ENZYME AND METHOD FOR PRODUCING SAME

Method of identifying a potential substrates of an O-methyltransferase

Crystallization of C-Jun N-Terminal Kinase 3 (JNK3)

Methods and compositions for treating cellular proliferative diseases

Antibodies to NTB-A

NOVEL HOMOLOGY MODEL OF THE GLYCOGEN SYNTHASE KINASE 3 ALPHA AND ITS USES THEREOF

Methods of using crystals of beta amyloid cleaving enzyme (BACE)

Method of identifying a FabK protein inhibitor using a three-dimensional structure of FabK protein

Three-dimensional structure of the APOBEC 2 structure, uses thereof, and methods for treating chronic and infectious diseases

PEPTIDES FOR DIAGNOSTIC AND THERAPEUTIC METHODS FOR CELIAC SPRUE

CRYSTAL STRUCTURE OF THE CARBOXYL TRANSFERASE DOMAIN OF HUMAN ACETYL-COA CARBOXYLASE 2 PROTEIN (ACC2 CT) AND USES THEREOF

Compositions and methods for crystallizing antibodies

Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3)

Binding moieties based on shark ignar domains

Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1

Crystal structure of an angiotensin-converting enzyme (ACE) and uses thereof

Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)

Crystal structure of human coronavirus 229E main proteinase and uses for developing SARS inhibitors

RAB9 PROTEIN CRYSTAL STRUCTURES AND METHODS FOR IDENTIFYING RAB9 MODULATORS

Crystalline enoyl-(acyl-carrier-protein) Reductase from Heliobacter Pylori

Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease

Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof

Crystal of a phosphatase of regenerating liver 1 (PRL-1) polypeptide and method of crystallization thereof

Crystallographic structure of Mnk-1 and Mnk-2 proteins

Methods for Building Atomic Models of Protein Molecules and Determining Drug Candidates Using MGST1

Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule

Methods of crystallizing antibodies

HDM2-INHIBITOR COMPLEXES AND USES THEREOF

DMO METHODS AND COMPOSITIONS

Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals

Human anti-KIR antibodies

KIR-binding agents and methods of use thereof

Crystal Structure of SMYD3 Protein

COMPOSITIONS AND METHODS FOR REGULATING INTRAMEMBRANE PROTEASES

Crystal structure of CMY-10, a β-lactamase causing antibiotic resistance with extended-substrate spectrum

Binding members for IgE molecules

RECOMBINANT PROTEIN VARIANTS

Crystal structure of Rho-kinase I kinase domain complexes and binding pockets thereof

Crystal of a cytochrome-ligand complex and methods of use

Antibodies to VLA-1

Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells

ANTIBODY VARIANTS

Structure of the hepatitis C NS5A protein

Methods for Identification of Modulators of Carm1 Methyl Transferase Activity

Glycogen synthase kinase-3 inhibitors

Method for crystallizing strain T1 lipase polypeptide

Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto

KIR-binding agents and methods of use thereof

Anti-CD154 antibodies

Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue

Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using

Crystal structure of the complex of hepatocyte growth factor beta chain with met receptor and methods of use

Crystal structure of polo-like kinase 3 (PLK3) and binding pockets thereof

Crystalline anti-human IL-12 antibodies

Compositions and methods for regulating apoptosis

Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

Peptides for active anti-cytokine immunization

Method of inhibitor design and identification using a 3-D structure of human peptide deformylase

Method of modulating cell survival, differentiation and/or synaptic plasticity

Position dependent recognition of GNN nucleotide triplets by zinc fingers

Crystal structure of estrogen receptor-beta complex and uses thereof

Protease crystals in broth

Crystallization and structure determination of beta secretase and/or beta secretase-like proteins

Hybrid proteins with ErbB4 extracellular domain and neuregulin heparin-binding domain for targeting

Regulation and function of TPL-2

CATALYTIC DOMAIN OF ADAM33 AND METHODS OF USE THEREOF

CRYSTAL STRUCTURE OF THE HEPATOCYTE GROWTH FACTOR AND METHODS OF USE

Computer comprising three-dimensional coordinates of a yeast RNA polymerase II

Alpha-Amylase Variants With Altered Properties

Treatment of Anemia Using TNFalpha Inhibitors

Method for identifying potential agonists or antagonists using the three-dimensional structure of caspase-7

Method for screening microcrystallizations for crystal formation

Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses Thereof

Methods for identifying modulators of cyclic nucleotide-gated cation channels

X-Ray Structure of Human Fpps and Use For Selecting Fpps Binding Compounds

Enzymatic Enantioselective Ester or Amide Hydrolysis or Synthesis

Method for Identifying Inhibitors Using a Homology Model of Polo-Like Kinase 1

Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase

Crystalline Form of Fatty Acid Amide Hydrolase (Faah)

Crystallographic structure of proline racemase and uses therefor

Method for Rational Pegylation of Proteins

Catalytically active recombinant memapsin and methods of use thereof

Purified FabI polypeptides from

Peptidomimetic modulators of cell adhesion

Methods for crystallizing ERK2 polypeptides

Selective resonant reconfiguration of chemical structures

Ribosomal Rna Methyltransferases Rima:Target Validation and Processes for Deleloping an Inhibitor Assay and Identification of Candidate Inhibitors

Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use

Crystal structure of CRIg and C3b:CRIg complex

Receptor modulators

Antibodies to IL-17A and uses thereof

Crystallized oxalate decarboxylase and methods of use

Maltogenic Alpha-Amylase Variants

Methods of screening based on the EGF receptor crystal structure

Inhibitors of Memapsin 2 and use thereof

Crystal Structure of a Receptor-Ligand Complex and Methods of Use

Characterization of the GSK-3beta protein and methods of use thereof

SAM Riboswitch and Uses Thereof

Method of Preparing a Dough-Based Product

Compositions and method for regulating ubiquitin-specific processing proteases

Crystal structure of the ternary complex of 14-3-3/Fusicoccin/PMA and methods for designing new herbicides

Methods of identifying insect-specific spider toxin mimics

Crystal Structure of Erbb2 and Uses Thereof

Protease Variants

ANTIBODY VARIANTS

Crystal structure and uses thereof

Protein crystal comprising the processivity clamp factor of DNA polymerase and a ligand, and its uses

Method for identifying or designing a candidate agent that interacts with LINGO-1 polypeptide using a LINGO-1 three-dimensional structure

Method for cyrstallizing human GSK3 and novel crystal structure thereof

Method for Predicting De Novo Biomacromolecule Crystallization Conditions and for Crystallization of the Same

Crystallization of antibody or fragment thereof

Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

Crystal of glucokinase protein, and method for drug design using the crystal

Three-dimensional structure of complement receptor type 2 and uses thereof

Recombinant soluble Fc receptors

Crystal structure of soluble glutaminyl cyclase

Soluble fusion proteins comprising heterologous polypeptides

Treatment of spondyloarthropathies using TNFalpha inhibitors

Fermentative preparation process for and crystal forms of cytostatics

Phosphate-binding protein, pharmaceutical compositions containing same and use thereof

Essential fungal CaYLR100w polypeptides, and methods of use

Peptides for stimulating an immune response against melanoma

Crystals of LuxP and complexes thereof

Aggrecanase structure

Crystal structure of TAK1-TAB1

Protein crystal structure

Anti-hiv-1 compounds based upon a conserved amino acid sequence shared by gp160 and the human cd4 protein

Essential fungal polypeptide, CaYDR341c, and methods of use thereof

Drug therapy for Celiac Sprue

Crystals of MarR polypeptides, regulators of multiple antibiotic resistance

Method of identifying inhibitors using a 3-D structure of RAC-1 GTPASE

Methods for identifying modified tumor necrosis factor-alpha converting enzyme inhibitors

Compositions and methods for regulating apoptosis

Crystal structure and uses thereof

Crystal structure and uses thereof

Altered antibodies having improved antigen-binding affinity

Crystal structure and uses thereof